Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
EV Eaton Vance Corp
CBU Community Bank System Inc
FPA First Trust Asia Pacific Ex-Japan AlphaDEX® Fund
GER Goldman Sachs MLP and Energy Renaissance Fund
FNX First Trust Mid Cap Core AlphaDEX® Fund
FNK First Trust Mid Cap Value AlphaDEX® Fund
FMK First Trust Mega Cap AlphaDEX® Fund
FLN First Trust Latin America AlphaDEX® Fund
FKU First Trust United Kingdom AlphaDEX® Fund
Go

Health Care : Pharmaceuticals |
Based in CanadaCompany profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Closing Price
$67.16
Day's Change
-3.09 (-4.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
69.88
Day's Low
66.50
Volume
(Light)
Volume:
1,610,588

10-day average volume:
2,029,334
1,610,588
Historical quotes & splits

Company Profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
145.08x
Price/Book (MRQ)
31.66x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

February 2019
Current Month
4.0M
Previous Month
3.8M
Percent of Float
5.23%
Days to Cover
2.1306 Days

Share Information

TLRY is in a share class of common stock
Float
59.6M
Shares Outstanding
93.2M
Institutions Holding Shares
119
% Held by Institutions

% Held by Institutions

Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.

10.06%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Brendan KennedyPres.
  • Mark CastanedaCFO
  • Edward Wood PastoriusOther
  • Andrew PucherOther
  • Michael Auerbach

Address

  • 1100 Maughan Rd
  • Nanaimo, BC V9X 1J2
  • Canada
  • Phone: 4169342141
  • Fax: 2507223954

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by , Copyright © 2019. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

3rd Party Research Disclosure